159 related articles for article (PubMed ID: 33420502)
1. Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study.
Tsuda H; Yoshida M; Akiyama F; Ohi Y; Kinowaki K; Kumaki N; Kondo Y; Saito A; Sasaki E; Nishimura R; Fujii S; Homma K; Horii R; Murata Y; Itami M; Kajita S; Kato H; Kurosumi M; Sakatani T; Shimizu S; Taniguchi K; Tamiya S; Nakamura H; Kanbayashi C; Shien T; Iwata H
Jpn J Clin Oncol; 2021 Mar; 51(3):434-443. PubMed ID: 33420502
[TBL] [Abstract][Full Text] [Related]
2. Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
Van Bockstal M; Baldewijns M; Colpaert C; Dano H; Floris G; Galant C; Lambein K; Peeters D; Van Renterghem S; Van Rompuy AS; Verbeke S; Verschuere S; Van Dorpe J
Histopathology; 2018 Dec; 73(6):923-932. PubMed ID: 30168167
[TBL] [Abstract][Full Text] [Related]
3. Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.
Dano H; Altinay S; Arnould L; Bletard N; Colpaert C; Dedeurwaerdere F; Dessauvagie B; Duwel V; Floris G; Fox S; Gerosa C; Jaffer S; Kurpershoek E; Lacroix-Triki M; Laka A; Lambein K; MacGrogan GM; Marchió C; Martinez DM; Nofech-Mozes S; Peeters D; Ravarino A; Reisenbichler E; Resetkova E; Sanati S; Schelfhout AM; Schelfhout V; Shaaban AM; Sinke R; Stanciu-Pop CM; Stobbe C; van Deurzen CHM; Van de Vijver K; Van Rompuy AS; Verschuere S; Vincent-Salomon A; Wen H; Bouzin C; Galant C; Van Bockstal MR
Mod Pathol; 2020 Mar; 33(3):354-366. PubMed ID: 31534203
[TBL] [Abstract][Full Text] [Related]
4. Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ.
Sneige N; Lagios MD; Schwarting R; Colburn W; Atkinson E; Weber D; Sahin A; Kemp B; Hoque A; Risin S; Sabichi A; Boone C; Dhingra K; Kelloff G; Lippman S
Hum Pathol; 1999 Mar; 30(3):257-62. PubMed ID: 10088542
[TBL] [Abstract][Full Text] [Related]
5. Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ.
Harrison BT; Hwang ES; Partridge AH; Thompson AM; Schnitt SJ
Mod Pathol; 2019 Sep; 32(9):1257-1262. PubMed ID: 30980039
[TBL] [Abstract][Full Text] [Related]
6. Variability in grading of ductal carcinoma in situ among an international group of pathologists.
van Seijen M; Jóźwiak K; Pinder SE; Hall A; Krishnamurthy S; Thomas JS; Collins LC; Bijron J; Bart J; Cohen D; Ng W; Bouybayoune I; Stobart H; Hudecek J; Schaapveld M; Thompson A; Lips EH; Wesseling J;
J Pathol Clin Res; 2021 May; 7(3):233-242. PubMed ID: 33620141
[TBL] [Abstract][Full Text] [Related]
7. Low-Grade Ductal Carcinoma In Situ.
Alghamdi SA; Krishnamurthy K; Garces Narvaez SA; Algashaamy KJ; Aoun J; Reis IM; Recine MA; Jorda M; Poppiti RJ; Gomez-Fernandez CR
Am J Clin Pathol; 2020 Feb; 153(3):360-367. PubMed ID: 31769792
[TBL] [Abstract][Full Text] [Related]
8. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes.
Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM
Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007
[TBL] [Abstract][Full Text] [Related]
9. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
[TBL] [Abstract][Full Text] [Related]
10. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology.
Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Coleman D; Connolly CE; Dervan P; Eusebi V; De Miguel C; Drijkoningen M; Elston CW; Faverley D; Gad A; Jacquemier J; Lacerda M; Martinez-Penuela J; Munt C; Peterse JL; Rank F; Sylvan M; Tsakraklides V; Zafrani B
Hum Pathol; 1998 Oct; 29(10):1056-62. PubMed ID: 9781641
[TBL] [Abstract][Full Text] [Related]
11. Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis.
Scott MA; Lagios MD; Axelsson K; Rogers LW; Anderson TJ; Page DL
Hum Pathol; 1997 Aug; 28(8):967-73. PubMed ID: 9269834
[TBL] [Abstract][Full Text] [Related]
12. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma.
Moriya T; Silverberg SG
Cancer; 1994 Dec; 74(11):2972-8. PubMed ID: 7954261
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and limitations of repeated slide conferences for improving interobserver agreement when judging nuclear atypia of breast cancer. The Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section.
Tsuda H; Akiyama F; Kurosumi M; Sakamoto G; Watanabe T
Jpn J Clin Oncol; 1999 Feb; 29(2):68-73. PubMed ID: 10089946
[TBL] [Abstract][Full Text] [Related]
14. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of interobserver agreement in nuclear atypia scoring of node-negative breast carcinomas judged at individual collaborating hospitals in the National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol.
Tsuda H; Akiyama F; Kurosumi M; Sakamoto G; Watanabe T
Jpn J Clin Oncol; 1999 Sep; 29(9):413-20. PubMed ID: 10563193
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast.
Bethwaite P; Smith N; Delahunt B; Kenwright D
J Clin Pathol; 1998 Jun; 51(6):450-4. PubMed ID: 9771444
[TBL] [Abstract][Full Text] [Related]
17. Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast.
Douglas-Jones AG; Morgan JM; Appleton MA; Attanoos RL; Caslin A; Champ CS; Cotter M; Dallimore NS; Dawson A; Fortt RW; Griffiths AP; Hughes M; Kitching PA; O'Brien C; Rashid AM; Stock D; Verghese A; Williams DW; Williams NW; Williams S
J Clin Pathol; 2000 Aug; 53(8):596-602. PubMed ID: 11002762
[TBL] [Abstract][Full Text] [Related]
18. Prognostic classification of breast ductal carcinoma-in-situ.
Silverstein MJ; Poller DN; Waisman JR; Colburn WJ; Barth A; Gierson ED; Lewinsky B; Gamagami P; Slamon DJ
Lancet; 1995 May; 345(8958):1154-7. PubMed ID: 7723550
[TBL] [Abstract][Full Text] [Related]
19. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
Tsang WY; Chan JK
Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients.
Collins LC; Achacoso NA; Nekhlyudov L; Fletcher SW; Haque R; Quesenberry CP; Alshak NS; Puligandla B; Brodsky GL; Schnitt SJ; Habel LA
Mod Pathol; 2007 Nov; 20(11):1149-55. PubMed ID: 17767135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
